Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series

Acta Derm Venereol. 2022 Aug 11:102:adv00754. doi: 10.2340/actadv.v102.2151.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Depression
  • Humans
  • Neurodermatitis*
  • Prurigo* / diagnosis
  • Prurigo* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab